single10MG
BPC-157
10MG Protocol
BPC-157 10MG
Injection Freq.
Inject once daily
Cycle Sched.
8–12 weeks; optional extension to 16 weeks
Reconstitution
3.0 mL BAC water
Supports tissue repair in preclinical gut, tendon, muscle, and skin models
Anti-inflammatory and cytoprotective activity reported in preclinical work
Good tolerability reported in early-phase safety research
1
Reconstitution Requirements
- 3.0 mL BAC water
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–2 | 200 mcg (0.2 mg) | 6 |
| 2 | Weeks 3–4 | 400 mcg (0.4 mg) | 12 |
| 3 | Weeks 5+ | 600 mcg (0.6 mg) | 18 |
Inject once daily
8–12 weeks; optional extension to 16 weeks
BPC-157 is a synthetic 15–amino-acid peptide derived from a sequence associated with gastric proteins and is widely discussed for cytoprotective and tissue-repair research. The protocol describes BPC-157 as influencing nitric oxide signaling and growth-factor networks that coordinate healing responses. In preclinical models, these effects are linked to enhanced angiogenesis, improved collagen organization, and more efficient tissue remodeling after injury. The peptide is also presented as having anti-inflammatory activity, which may help create a biochemical environment that supports recovery across soft tissue and gastrointestinal contexts. Experimental data cited by the protocol include accelerated healing in gut, tendon/ligament, muscle, and skin models. Human evidence is described as limited—referencing early safety work and small reports—so the mechanism is framed primarily through animal and in vitro findings rather than definitive clinical outcomes.
Mild injection-site reactions (redness/itching)
Limited long-term human safety/efficacy data
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)